201 related articles for article (PubMed ID: 33032525)
21. Malignant mesothelioma, airborne asbestos, and the need for accuracy in chrysotile risk assessments.
Meisenkothen C
New Solut; 2013 Jan; 23(2):389-405. PubMed ID: 23896078
[TBL] [Abstract][Full Text] [Related]
22. Antigen spreading-induced CD8+T cells confer protection against the lethal challenge of wild-type malignant mesothelioma by eliminating myeloid-derived suppressor cells.
Yu Z; Tan Z; Lee BK; Tang J; Wu X; Cheung KW; Lo NT; Man K; Liu L; Chen Z
Oncotarget; 2015 Oct; 6(32):32426-38. PubMed ID: 26431275
[TBL] [Abstract][Full Text] [Related]
23. DNA methylation profiling of asbestos-treated MeT5A cell line reveals novel pathways implicated in asbestos response.
Casalone E; Allione A; Viberti C; Pardini B; Guarrera S; Betti M; Dianzani I; Aldieri E; Matullo G
Arch Toxicol; 2018 May; 92(5):1785-1795. PubMed ID: 29523930
[TBL] [Abstract][Full Text] [Related]
24. Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time.
Pasello G; Zago G; Lunardi F; Urso L; Kern I; Vlacic G; Grosso F; Mencoboni M; Ceresoli GL; Schiavon M; Pezzuto F; Pavan A; Vuljan SE; Del Bianco P; Conte P; Rea F; Calabrese F
Ann Oncol; 2018 May; 29(5):1258-1265. PubMed ID: 29514216
[TBL] [Abstract][Full Text] [Related]
25. Clinical-Grade Human Multipotent Adult Progenitor Cells Block CD8+ Cytotoxic T Lymphocytes.
Plessers J; Dekimpe E; Van Woensel M; Roobrouck VD; Bullens DM; Pinxteren J; Verfaillie CM; Van Gool SW
Stem Cells Transl Med; 2016 Dec; 5(12):1607-1619. PubMed ID: 27465071
[TBL] [Abstract][Full Text] [Related]
26. Enhanced suppression of polyclonal CD8
Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
[TBL] [Abstract][Full Text] [Related]
27. Mesothelioma in a worker who spun chrysotile asbestos at home during childhood.
Yano E; Wang ZM; Wang XR; Wang MZ; Takata A; Kohyama N; Suzuki Y
Am J Ind Med; 2009 Apr; 52(4):282-7. PubMed ID: 19143009
[TBL] [Abstract][Full Text] [Related]
28. Electricians' chrysotile asbestos exposure from electrical products and risks of mesothelioma and lung cancer.
Goodman JE; Peterson MK; Bailey LA; Kerper LE; Dodge DG
Regul Toxicol Pharmacol; 2014 Feb; 68(1):8-15. PubMed ID: 24189076
[TBL] [Abstract][Full Text] [Related]
29. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.
Clayton A; Mitchell JP; Court J; Mason MD; Tabi Z
Cancer Res; 2007 Aug; 67(15):7458-66. PubMed ID: 17671216
[TBL] [Abstract][Full Text] [Related]
30. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141
[TBL] [Abstract][Full Text] [Related]
31. Reduction of CXC chemokine receptor 3 in an in vitro model of continuous exposure to asbestos in a human T-cell line, MT-2.
Maeda M; Nishimura Y; Hayashi H; Kumagai N; Chen Y; Murakami S; Miura Y; Hiratsuka J; Kishimoto T; Otsuki T
Am J Respir Cell Mol Biol; 2011 Sep; 45(3):470-9. PubMed ID: 21148743
[TBL] [Abstract][Full Text] [Related]
32. IL-12 stimulates CTLs to secrete exosomes capable of activating bystander CD8
Li L; Jay SM; Wang Y; Wu SW; Xiao Z
Sci Rep; 2017 Oct; 7(1):13365. PubMed ID: 29042682
[TBL] [Abstract][Full Text] [Related]
33. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():49-73. PubMed ID: 18686078
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic T cell responses against mesothelioma by apoptotic cell-pulsed dendritic cells.
Ebstein F; Sapede C; Royer PJ; Marcq M; Ligeza-Poisson C; Barbieux I; Cellerin L; Dabouis G; Grégoire M
Am J Respir Crit Care Med; 2004 Jun; 169(12):1322-30. PubMed ID: 15070823
[TBL] [Abstract][Full Text] [Related]
35. An updated evaluation of reported no-observed adverse effect levels for chrysotile asbestos for lung cancer and mesothelioma.
Pierce JS; Ruestow PS; Finley BL
Crit Rev Toxicol; 2016 Aug; 46(7):561-86. PubMed ID: 27031024
[TBL] [Abstract][Full Text] [Related]
36. Autologous high-killing cytotoxic T lymphocytes against human lung cancer are induced using interleukin (IL)-1beta, IL-2, IL-4, and IL-6: possible involvement of dendritic cells.
Saijo Y; Hong X; Tanaka M; Tazawa R; Liu SQ; Saijo K; Ohno T; Koike K; Ohkuda K; Satoh K; Nukiwa T
Clin Cancer Res; 1999 May; 5(5):1203-9. PubMed ID: 10353758
[TBL] [Abstract][Full Text] [Related]
37. Elevated binding activity of CD8+ cells with phytohaemagglutinin by asbestos fibre in vitro.
Kinugawa K; Hyodoh F; Andoh A; Ueki A; Tanaka H; Mochizuki Y
Clin Exp Immunol; 1990 Apr; 80(1):89-93. PubMed ID: 2157569
[TBL] [Abstract][Full Text] [Related]
38. Flowcytometric immunophenotyping of peripheral-blood leukocytes in relation to immunopathology and cellular proliferation of pleural mesothelioma.
ElGendy AM; Abbas Helmy WH; Ezz-ElArab A
Egypt J Immunol; 2006; 13(1):87-98. PubMed ID: 17974153
[TBL] [Abstract][Full Text] [Related]
39. [Regulation of immunological balance between TH1/TH2 and Tc1/Tc2 lymphocytes by prostaglandin E2].
Bao YS; Wang M; Zhang P; Zhou Z; Zhai WJ; Wang H; Jiang EL; Huang Y; Feng SZ; Han MZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):431-5. PubMed ID: 20416182
[TBL] [Abstract][Full Text] [Related]
40. An evaluation of reported no-effect chrysotile asbestos exposures for lung cancer and mesothelioma.
Pierce JS; McKinley MA; Paustenbach DJ; Finley BL
Crit Rev Toxicol; 2008; 38(3):191-214. PubMed ID: 18324516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
